L92.1
Necrobiosis lipoidica, not elsewhere classified
Clinical Classification Guidelines
Excludes Type 1
- necrobiosis lipoidica associated with diabetes mellitus (E08-E13 with .620)
Medical Intelligence & Overview
Necrobiosis lipoidica is a rare chronic skin condition characterized by the formation of yellowish plaques with a reddish or purple outline, primarily appearing on the lower legs. It often affects individuals with diabetes mellitus, although the exact cause remains unclear. The condition is considered a type of granulomatous skin disorder, involving changes in the skin's collagen and immune response. While it can be persistent and sometimes troublesome, necrobiosis lipoidica generally has a slow progression and may resolve or stabilize over time. Proper understanding and management are essential to prevent complications and improve skin appearance.
Causes & Symptoms
Clinical Causes: Diabetes mellitus, especially poorly controlled diabetes Immune system dysregulation Genetic predisposition Vascular abnormalities affecting blood flow to the skin Trauma or injury to the skin
Key Symptoms: Yellowish, waxy plaques that are gradually enlarging Lesions with irregular borders and a reddish or purple outline Typically located on the shins or other lower leg areas Possible ulceration or breaking of the skin in advanced cases Discoloration and induration (hardening) of affected skin Minimal to no discomfort, though some may experience mild itching or tenderness
Diagnostic & Treatment
Diagnosis Path: Clinical examination to observe characteristic skin changes Skin biopsy to identify granulomatous inflammation and tissue changes Blood tests to check blood sugar levels and rule out other conditions Imaging studies, if vascular involvement is suspected
Treatment Protocols: Topical corticosteroids to reduce inflammation Immunomodulating agents, such as tacrolimus ointment Phototherapy such as PUVA (psoralen plus ultraviolet A) Managing underlying diabetes effectively Wound care for ulcerated lesions In some cases, surgical interventions or laser therapy may be considered
Clinical Advice & FAQs
Billing Guidance
Is L92.1 a billable ICD-10 code?
Yes, L92.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L92.1?
Clinical documentation must specify the nature of Necrobiosis lipoidica, not elsewhere classified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference